Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,636.7
26.5 (1.02%)

 

  • STI Straits Times Index
    2,636.7
    26.5 (1.02%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,536.3
    21.9 (1.44%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,124.2
    697.0 (2.85%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,090.6
    64.6 (2.13%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,146.0
    24.2 (0.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,966.8
    52.4 (1.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,559.7M
  • Value: 1,083.5M
  • Rise: 238
  • Fall: 120
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
BlackGoldNatural0.020+0.008
Singapore-eDev0.116+0.002
Medtecs Intl0.465+0.055
Jadason0.033+0.002
Broadway Ind0.124+0.008
Rex Intl0.180-0.001
Oceanus^0.007-
NetLink NBN Tr0.960-0.015
New Wave0.012+0.005
Sino Grandness0.024-

World Indices

World Indices
Name Last Change
Nasdaq 10,154.6 +95.9
HSI 25,124.2 +697.0
HSCEI 10,056.9 +298.2
Jakarta 4,966.8 +52.4
Nikkei 225 22,146.0 +24.2
SSE Comp 3,090.6 +64.6
Shanghai A 3,239.5 +67.7
Shanghai B 219.5 +4.7
KOSPI 2,135.4 +28.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIOMARIN PHARMACEUTICAL BIOMARIN PHARMACEUTICAL
Updated on 01 Jul 2020 (End of trading day)
Last (USD): 125.840 Change: +2.500 High: 128.770 Remarks: -
Change (%): +2.03 Low: 121.660
Open 123.010 Yesterday's Close 123.34
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,146,449 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13188 Trailing EPS (USD) e 0.63044 NAV (USD) b 17.9165
PE a - Trailing PE f 199.608 Price / NAV b 7.0237
Dividend (USD) d - Cash In Hand (USD) g 2.6357 Issued & Paid-up Shares c 180,837,000
Dividend Yield (%) d - Price / Cash In Hand g 47.744 Treasury Shares h -
Market Cap (M) 22,756.528 Enterprise Value (M) 22,811.583
Piotroski F Score 4 Exchange Code BMRN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 40.85 Free Float (%) 99.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIOMARIN PHARMACEUTICAL NASDAQ 22,756.528 - 199.608 7.0237 -
Industry Biotechnology NASDAQ 2,940.147 356.213 6455.431 7.0461 0.654
Local Peer AMGEN INC NASDAQ 150,073.575 19.137 19.554 15.8222 2.286
Local Peer GILEAD SCIENCES INC NASDAQ 95,407.382 17.714 19.228 4.3235 3.344
Local Peer VERTEX PHARMACEUTICAL NASDAQ 74,225.820 63.074 49.126 11.4871 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 68,545.008 32.397 30.073 5.6495 -
Local Peer ILLUMINA INC NASDAQ 54,176.850 54.069 57.513 11.6886 -
Local Peer BIOGEN INC NASDAQ 43,207.022 7.338 7.350 3.4436 -
Local Peer SEATTLE GENETICS INC NASDAQ 28,998.047 - - 16.4237 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,818.747 10.323 10.454 2.1126 -
Local Peer MODERNA INC NASDAQ 23,947.670 - - 14.5944 -
Local Peer INCYTE CORPORATION NASDAQ 22,313.338 49.928 - 11.5152 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 17,081.623 - - 12.6556 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 14,714.326 - - 5.2324 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), NOVAVAX INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VAXCYTE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MACROGENICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VERACYTE INC (NASDAQ), ARVINAS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), COMPUGEN (NASDAQ), TRANSLATE BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), BELLUS HEALTH INC (NASDAQ), AKOUOS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AGENUS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AVROBIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ARDELYX INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KAMADA (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AFFIMED N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), MEDICINOVA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), XOMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), CHIASMA INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ARAVIVE INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMV INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), OTONOMY INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), COHBAR INC (NASDAQ), SYNLOGIC INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VACCINEX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EQUILLIUM INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), PRECIPIO INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 129,131.536 48.131 44.577 14.9313 0.933
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,206.341 25.403 39.834 5.7060 0.745
Global Peer SINO BIOPHARM HKEx 185,101.202 60.307 60.860 5.3425 0.542
Global Peer WUXI BIO HKEx 182,853.428 159.063 159.062 12.7865 -
Global Peer BEIGENE HKEx 121,316.400 - - 5.5657 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,294.361 78.796 63.060 3.9955 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 30,698.355 - - 10.2923 -
Global Peer 3SBIO HKEx 25,740.390 23.313 23.313 2.3908 -
Other Global Peers ALPHAMAB-B (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), HAOHAI BIOTEC (HKEx), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), KADMON HLDGS INC (NYSE), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), DPHARMA (Bursa), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), AIM IMMUNOTECH INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), CT ENTERPRISE (HKEx), ORAGENICS INC (NYSE American), BIOTRON (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), MEMPHASYS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), REGENT PACIFIC (HKEx), ANTEOTECH LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), Suntar Eco-City (SGX), SIENNA CANCER DIAGNOSTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HAO WEN HLDGS (HKEx), AMPLIA THERAPEUTICS LTD (ASX), LEAF RESOURCES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.620
+1.30 %
10 Days -+12.010
+10.55 %
20 Days -+18.330
+17.05 %
Medium Term Return 3 Months -+39.780
+46.22 %
6 Months -+41.800
+49.74 %
1 Year -+41.690
+49.54 %
Long Term Return 2 Years -+30.340
+31.77 %
3 Years -+35.760
+39.70 %
5 Years --14.290
-10.20 %
Annualised Return Annualised --
-2.13 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 62.880 - 124.950 Change From 1 Year Low +62.960 % Change From 1 Year Low (%) +100.13
Change From 1 Year High +0.890 % Change From 1 Year High (%) +0.71
2 Years Range 62.880 - 124.950 Change From 2 Years Low +62.960 % Change From 2 Years Low (%) +100.13
Change From 2 Years High +0.890 % Change From 2 Years High (%) +0.71
5 Years Range 62.120 - 151.750 Change From 5 Years Low +63.720 % Change From 5 Years Low (%) +102.58
Change From 5 Years High -25.910 % Change From 5 Years High (%) -17.07
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
01 Jul 2020 123.010 128.770 121.660 125.840 2,146,449 -
30 Jun 2020 122.190 123.920 120.660 123.340 1,188,700 -
29 Jun 2020 124.780 124.780 121.460 122.180 1,273,851 -
26 Jun 2020 123.610 124.950 121.240 124.020 2,864,885 -
25 Jun 2020 120.570 124.740 120.390 124.220 2,119,786 -
24 Jun 2020 121.300 122.635 118.890 120.630 1,508,688 -
23 Jun 2020 123.010 123.810 121.010 121.720 1,507,365 -
22 Jun 2020 122.380 123.770 118.380 122.340 2,223,620 -
19 Jun 2020 114.140 124.950 113.830 124.120 4,546,236 -
18 Jun 2020 114.370 115.950 112.250 113.830 2,123,718 -
17 Jun 2020 106.490 113.840 103.850 111.320 2,502,433 -
16 Jun 2020 107.860 107.900 105.010 106.470 907,191 -
15 Jun 2020 105.030 106.800 103.382 105.760 1,268,406 -
12 Jun 2020 106.060 106.805 103.080 105.720 1,135,020 -
11 Jun 2020 106.680 107.290 103.860 103.860 1,327,005 -
10 Jun 2020 107.560 108.550 106.140 107.660 1,374,845 -
09 Jun 2020 106.840 107.500 104.840 105.090 1,012,345 -
08 Jun 2020 105.190 107.330 104.230 106.870 1,026,049 -
05 Jun 2020 107.460 109.710 105.220 105.800 1,297,769 -
04 Jun 2020 109.940 112.572 106.840 107.510 1,538,891 -
03 Jun 2020 108.340 112.390 107.386 111.210 1,994,349 -
02 Jun 2020 106.710 108.557 105.500 108.330 1,163,918 -
Summary
Current 2 Weeks
(18 Jun 2020 to 01 Jul 2020)
114.370 128.770 112.250 125.840 21,503,298 -
Previous 2 Weeks
(04 Jun 2020 to 17 Jun 2020)
109.940 128.770 106.840 111.320 13,389,954 -
4 Weeks from
(06 May 2020 to 03 Jun 2020)
93.750 128.770 93.430 111.210 35,330,613 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.